Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › TWST

FARALLON CAPITAL MANAGEMENT, L.L.C. position in TWST

TWIST BIOSCIENCE CORP · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 2,136,400 shares of TWST (TWIST BIOSCIENCE CORP) in its Q2 2026 13F filing — a position valued at US$219.8M, representing 1.02% of its reported portfolio and ranking #26 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed TWST holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)2.14M sh
Reported value held$219.79M
Portfolio Weight1.02%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s TWST position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in TWST in Q2 2024 at 192,000 shares (US$9.5M). The position peaked in Q2 2026 at 2,136,400 shares, worth US$219.8M. Across 9 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 2,136,400 shares valued at US$219.8M — an increase of 708,750 shares quarter over quarter.. Notable position changes include a 77% increase in Q3 2024 (shares rose 3% over the following quarter), a 98% trim in Q4 2024 (shares fell 16% over the following quarter), a 18562% increase in Q1 2026 (shares rose 116% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 192.00K $9.46M New
Q3 2024 340.65K $15.39M Add
Q4 2024 7.65K $355.50K Reduce
Q1 2025 7.65K $300.34K Hold
Q2 2025 7.65K $281.44K Hold
Q3 2025 7.65K $215.27K Hold
Q4 2025 7.65K $242.66K Hold
Q1 2026 1.43M $67.84M Add
Q2 2026 2.14M $219.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TWST and 13F data

TWST (TWIST BIOSCIENCE CORP) is a Health Care company. 56 other funds we track also report a position in TWST — the largest reported positions include Artisan Partners Limited Partnership (US$494.0M), ARK Invest (US$468.1M), EdgePoint Investment Group Inc. (US$259.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TWST

All TWST fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held TWST?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed TWST holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in TWST?

As of Q2 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 2.14M shares of TWST (TWIST BIOSCIENCE CORP), valued at $219.79M, representing 1.02% of its reported portfolio and ranking #26.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling TWST?

In the latest 13F filing (Q2 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. increased its position in TWST. The position peaked in Q2 2026 at 2.14M shares.

Which other funds hold TWST?

Other major institutional holders of TWST include Artisan Partners Limited Partnership, ARK Invest, EdgePoint Investment Group Inc., among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.